Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie L Stocker

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Alimentary Pharmacology & Therapeutics|January 22, 2020
The safety and pharmacokinetics of metformin in patients with chronic liver diseaseFelicity C Smith, Sophie L Stocker, Mark Danta, et al.
British Journal of Clinical Pharmacology|September 1, 2019
Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysisChristina Abdel Shaheed, Jane E Carland, Garry G Graham, et al.
Clinical Pharmacokinetics|February 10, 2026
Single Saliva Sample Model-Informed Precision Dosing of Levofloxacin for Multidrug-Resistant TuberculosisThi A Nguyen, Tri P Nguyen, Anh T Nguyen, et al.
The European Respiratory Journal|January 22, 2026
Saliva point-of-care testing for suboptimal levofloxacin and linezolid exposure in multidrug-resistant tuberculosisThi A Nguyen, Anh T Nguyen, Luong V Dinh, et al.
British Journal of Clinical Pharmacology|March 26, 2021
Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practicesJane E Carland, Sophie L Stocker, Melissa T Baysari, et al.
Therapeutic Drug Monitoring|December 9, 2021
Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStephanie E Reuter, Sophie L Stocker, Jan-Willem C Alffenaar, et al.
Clinical Pharmacokinetics|November 25, 2015
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of MetforminJennifer E Hibma, Arik A Zur, Richard A Castro, et al.
Journal of Pharmaceutical Sciences|May 8, 2013
Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8)Sook Wah Yee, Anh Nguyet Nguyen, Chaline Brown, et al.
Pharmacogenetics and Genomics|December 17, 2016
Characterization of ADME gene variation in 21 populations by exome sequencingDaniel H Hovelson, Zhengyu Xue, Matthew Zawistowski, et al.
Clinical Pharmacology and Therapeutics|August 10, 2018
Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical ImportanceMaciej J Zamek-Gliszczynski, Mitchell E Taub, Paresh P Chothe, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Alimentary Pharmacology & Therapeutics|January 22, 2020
The safety and pharmacokinetics of metformin in patients with chronic liver diseaseFelicity C Smith, Sophie L Stocker, Mark Danta, et al.
British Journal of Clinical Pharmacology|September 1, 2019
Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysisChristina Abdel Shaheed, Jane E Carland, Garry G Graham, et al.
Clinical Pharmacokinetics|February 10, 2026
Single Saliva Sample Model-Informed Precision Dosing of Levofloxacin for Multidrug-Resistant TuberculosisThi A Nguyen, Tri P Nguyen, Anh T Nguyen, et al.
The European Respiratory Journal|January 22, 2026
Saliva point-of-care testing for suboptimal levofloxacin and linezolid exposure in multidrug-resistant tuberculosisThi A Nguyen, Anh T Nguyen, Luong V Dinh, et al.
British Journal of Clinical Pharmacology|March 26, 2021
Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practicesJane E Carland, Sophie L Stocker, Melissa T Baysari, et al.
Therapeutic Drug Monitoring|December 9, 2021
Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStephanie E Reuter, Sophie L Stocker, Jan-Willem C Alffenaar, et al.
Clinical Pharmacokinetics|November 25, 2015
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of MetforminJennifer E Hibma, Arik A Zur, Richard A Castro, et al.
Journal of Pharmaceutical Sciences|May 8, 2013
Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8)Sook Wah Yee, Anh Nguyet Nguyen, Chaline Brown, et al.
Pharmacogenetics and Genomics|December 17, 2016
Characterization of ADME gene variation in 21 populations by exome sequencingDaniel H Hovelson, Zhengyu Xue, Matthew Zawistowski, et al.
Clinical Pharmacology and Therapeutics|August 10, 2018
Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical ImportanceMaciej J Zamek-Gliszczynski, Mitchell E Taub, Paresh P Chothe, et al.
Pageof 10